Latest Content

AC699 Fast-Tracked for ESR1-Mutant Breast Cancer

August 15th 2024, 1:00pm

By Brielle Benyon

The Food and Drug Administration will fast-track the development of AC699 for patients with ER-positive, HER2-negative ESR1-mutant advanced or metastatic breast cancer.

Less-Intense Chemotherapy May Be Preferrable in Older Patients with AML

August 14th 2024, 8:00pm

By Alex Biese

Article

Researchers compared health-related quality of life among patients ages 60 and older with acute myeloid leukemia undergoing different chemotherapy regimens.

FDA Approves Niktimvo for Chronic GVHD

August 14th 2024, 7:36pm

By Brielle Benyon

Article

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.

When CML Therapy Shifts: Collaborative Approaches to Treatment Changes

August 14th 2024, 6:10pm

By Jorge E. Cortes, MD

Video

Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.

Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life

August 14th 2024, 6:04pm

By Jorge E. Cortes, MD

Video

A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.

The Right Mindset Helped Me Focus on Healing After Stage 4 Cancer

August 14th 2024, 5:00pm

By Steve Rubin

Article

Reflecting on different reminders that have helped me maintain an empowering mindset and stay motivated on healing with cancer, one day at a time.

Dose-Dense Chemo for Muscle-Invasive Bladder Cancer May Be Feasible

August 14th 2024, 3:34pm

By Ashley Chan

Article

Patients with locally advanced muscle-invasive bladder cancer may benefit from dose-dense gemcitabine and cisplatin.

I Found ‘My Place’ After Being Diagnosed With Cancer

August 14th 2024, 1:00pm

By Mary Joan Nastri

Article

My local Gilda’s Club chapter helped me through cancer, so I continued to go after finishing treatment

Olomorasib, Keytruda Combo Is Safe for Lung Cancer Subset

August 13th 2024, 7:00pm

By Courtney Flaherty

Article

Olomorasib plus Keytruda was proven to be safe and well tolerated for patients with KRAS G12C-mutant non-small cell lung cancer.

Is It Possible to Forget Having Breast Cancer?

August 13th 2024, 5:00pm

By Bonnie Annis

Article

After a decade of surviving cancer, I’ve wondered if it’s possible to truly forget I had breast cancer. After a small incident, I thought perhaps it was possible. Now I’m not so sure.

TILs in Early Stage TNBC May Have Potential as Biomarker

August 13th 2024, 3:10pm

By Ashley Chan

Article

Levels of tumor-infiltrating lymphocytes in patients with stage 1 triple-negative breast cancer may be a biomarker to help with optimized treatment plans.